Phrenic long-term facilitation following severe acute intermittent hypoxia is preserved in geriatric male rats

老年雄性大鼠在严重急性间歇性缺氧后仍保留膈神经长期易化作用

阅读:1

Abstract

Acute intermittent hypoxia (AIH) elicits a form of respiratory motor plasticity known as phrenic long-term facilitation (pLTF). Although AIH comprised of moderate versus severe hypoxic episodes both elicit pLTF, they do so via completely distinct cellular mechanisms. In young adult male rats, moderate AIH (mAIH) elicits pLTF via a serotonin-driven, adenosine-constrained mechanism. In aged rats, mAIH-induced pLTF is diminished due to increased basal spinal adenosine levels that further constrain serotonin-driven pLTF. In contrast, in young male rats, severe AIH (sAIH) elicits pLTF via an adenosine-dominant, serotonin-constrained mechanism. Since basal spinal adenosine levels are elevated in aged male rats, we tested the hypothesis that adenosine-dependent, sAIH-induced pLTF is enhanced in aged versus young male rats. Young (∼3 mo) and aged (∼20 mo) male Sprague-Dawley rats were urethane-anesthetized, ventilated, vagotomized, paralyzed, and exposed to sAIH (3, 5-min episodes, arterial Po(2) = 25-30 mmHg; 5-min intervals). Integrated phrenic nerve activity was measured before (baseline), during each hypoxic episode, and for 60 min post sAIH. Neither baseline phrenic burst amplitude, the short-term hypoxic phrenic response, nor pLTF (% change from baseline in phrenic burst amplitude) were different in aged versus young male rats (132 ± 19% vs. 99 ± 17%, respectively). Thus, although sAIH-induced pLTF is not significantly elevated in aged versus young male rats as predicted, the capacity for adenosine-driven plasticity is preserved, in contrast with serotonin-dependent, mAIH-induced pLTF.NEW & NOTEWORTHY We report new findings that advance our understanding of how cellular mechanisms underlying respiratory motor plasticity shift with age. Age-related shifts in the magnitude or mechanism driving plasticity have major clinical relevance as we work to translate AIH for therapeutic benefit in conditions such as chronic spinal cord injury or ALS, where subjects in ongoing clinical trials are often males of advanced age.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。